Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  JSW Steel strengthens on executing a share purchase agreement with Praxair India

16-Aug2016

JSW Steel strengthens on executing a share purchase agreement with Praxair India

JSW Steel is currently trading at Rs 1748.45, up by 23.70 points or 1.37% from its previous closing of Rs 1724.75 on the BSE.

The scrip opened at Rs. 1724.00 and has touched a high and low of Rs. 1753.00 and Rs. 1716.95 respectively. So far 39129 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1762.00 on 27-Jul-2016 and a 52 week low of Rs. 829.35 on 25-Aug-2015.

Last one week high and low of the scrip stood at Rs. 1756.75 and Rs. 1685.00 respectively. The current market cap of the company is Rs. 42059.64 crore.

The promoters holding in the company stood at 41.48%, while Institutions and Non-Institutions held 37.61% and 20.91% respectively.

JSW Steel has executed a Share Purchase Agreement with Praxair India to acquire their entire shareholding of 74% in JSW Praxair Oxygen (JPOPL) for a cash consideration of Rs 240 crore. The company currently holds 26 percent of the equity shares of JPOPL and post the aforesaid acquisition, JPOPL would become a wholly owned subsidiary of JSW Steel.

JPOPL is engaged in the business of production and sale of industrial gases such as oxygen, nitrogen and argon and has set up two air separation plants, each with a capacity of 2500 tonnes per day, at Toranagallu, Bellary District in Karnataka JSW Steel currently sources industrial gases from JPOPL amongst others at prices based on long term contracts.

The said acquisition is strategic in nature as it will provide the Company the benefit of backward integration of this critical input. Deloitte Touche Tohmatsu India LLP and Bharucha & Partners, Advocates and Solicitors carried out financial and legal due diligence respectively for the Company.


Related News

View all news

IndiGo trades in green on the BSE

Interglobe Aviation (IndiGo) is currently trading at Rs. 1063.55, up by 20.35 points or 1.95% from its previous closing of Rs. 1043.20 on the BSE.The scrip opened at Rs. 1034.00 and has touched a high......

Shilpa Medicare surges on getting tentative ANDA approval for Dimethyl Fumarate DR Capsules

Shilpa Medicare is currently trading at Rs. 388.65, up by 14.65 points or 3.92% from its previous closing of Rs. 374.00 on the BSE.The scrip opened at Rs. 383.95 and has touched a high and low of Rs. 399.75......

Pfizer shines despite reporting 14% fall in Q2 net profit

Pfizer is currently trading at Rs. 2865.00, up by 86.25 points or 3.10% from its previous closing of Rs. 2778.75 on the BSE.The scrip opened at Rs. 2815.50 and has touched a high and low of Rs. 2866.80......

Top News

View all news

Karnataka Bank launches CASA campaign

Karnataka Bank has launched Current & Savings Accounts campaign (CASA) of FY 2018-19 and introduced a new SB scheme 'KBL SB - TASC' a specialized product for Trusts/Associates/Societies/Clubs.Under......

M&M's arm opens manufacturing hub in Bengaluru

Mahindra & Mahindra's (M&M) subsidiary -- Mahindra Electric Mobility has opened its electric technology manufacturing hub set up with an investment of Rs 100 crore in Bengaluru. The plant......

Venus Remedies reports positive result in Phase-3 Clinical Trials for ELORES

Venus Remedies has reported positive Top-Line results in its Phase-3 Clinical Trials for its flagship product ELORES. The results were presented at IDWeek 2018 in San Francisco. IDWeek is an annual scientific......